Register
Login:
Share:
Email Facebook Twitter

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money' Watch here

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018


DCC Broker Ratings



Broker Ratings for DCC (DCC)


Share Price: 7,155.00Bid: 7,150.00Ask: 7,160.00Change: 0.00 (0.00%)No Movement on Dcc
Spread: 10.00Spread as %: 0.14%Open: 7,150.00High: 7,185.00Low: 7,110.00Yesterday’s Close: 7,155.00


Broker Recommendations for DCC (DCC)
DateBrokerRatingOld TargetNew TargetChange
17-Nov-17Berenberg BankBuy8,500.008,700.00Reiteration
15-Nov-17JP Morgan CazenoveOverweight-8,160.00Reiteration
07-Nov-17Berenberg BankBuy8,500.008,500.00Reiteration
07-Nov-17Canaccord GenuityBuy8,000.008,000.00Reiteration
07-Nov-17JP Morgan CazenoveOverweight8,160.008,160.00Reiteration
01-Jun-17Goldman SachsBuy-8,200.00Reiteration
30-May-17Canaccord GenuityBuy8,000.008,000.00Reiteration
16-May-17Canaccord GenuityBuy-8,000.00Reiteration
09-May-17JefferiesBuy7,500.008,500.00Reiteration
21-Apr-17Berenberg BankBuy-8,500.00Reiteration
27-Mar-17Goldman SachsBuy7,400.008,200.00Reiteration
09-Feb-17Canaccord GenuityBuy7,800.008,000.00Reiteration
08-Feb-17JP Morgan CazenoveOverweight7,843.008,160.00Reiteration
08-Feb-17UBSBuy8,100.008,400.00Reiteration
30-Jan-17Goldman SachsBuy-7,400.00Reiteration


Registered members see more DCC broker ratings!
Sign up here for your free account.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.